Physician profile
Elizabeth Chan
NPI 1104351352
$16,538.70
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.49 · 2020: $279 · 2021: $8,502 · 2022: $6,171 · 2023: $945 · 2024: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Travel and Lodging: $524 · Long Term Medical Supply Or Device Loan: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.88 |
| Travel and Lodging | $523.90 |
| Long Term Medical Supply Or Device Loan | $504.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $10,800.48 | 2021-2022 | |
| Arthrex, INC. | $3,409.20 | 2021-2022 | |
| Treace Medical Concepts, INC. | $623.53 | 2023 | |
| Integra Lifesciences Corporation | $514.16 | 2024 | Integra, Acell, Primatrix |
| Smith+Nephew, INC. | $268.46 | 2019-2024 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Stryker Corporation | $213.09 | 2020-2023 | Augment Injectable, Citrefix |
| Paragon 28, INC. | $192.00 | 2021-2023 | Portfolio |
| Nevro Corp. | $156.14 | 2023-2024 | Senza |
| Kerecis Limited | $126.35 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $124.15 | 2020 | |
| Triad Life Sciences INC. | $40.91 | 2022 | |
| Novastep INC. | $26.69 | 2022 | |
| Orthofix Medical, INC. | $17.22 | 2023 | Physio-Stim |
| Kci USA, INC. | $14.35 | 2020 | |
| Paratek Pharmaceuticals, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.